Oruka Therapeutics, Inc. · NASDAQ:ORKA
Harwin Peter Evan reported a 19.50% stake in Oruka Therapeutics, Inc. (Schedule 13D/A)
Event Jul 1, 2026 · Filed Jul 1, 2026
Harwin Peter Evan reported a 19.50% stake in Oruka Therapeutics, Inc., 14,572,917 shares, with active intent on Jul 1, 2026. Filed Jul 1, 2026 (Schedule 13D/A).
- Stake
- 19.50%
- Shares
- 14,572,917
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Fairmount Funds Management LLC | 19.47% | 14,553,895 |
| Fairmount Healthcare Fund II L.P. | 16.03% | 11,980,587 |
| Fairmount Healthcare Co-Invest III L.P. | 4.03% | 2,573,308 |
| Harwin Peter Evan | 19.50% | 14,572,917 |
| Kiselak Tomas | 19.47% | 14,533,895 |